Viking Therapeutics stockVKTX
Viking Therapeutics trades at $25.79, 40.2% below its 52-week high (Nov 12, 2025). The price is below its 50- and 200-day averages, a downtrend. −26.7% year to date, −29.3% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 10, 2027.
Ratings, candles, signals and the screener for VKTX — after you log in
Open the terminalFrequently asked questions about Viking Therapeutics
What is the Viking Therapeutics stock price?
At the close on Nov 5, 2026: $25.79 (−7.79% on the day). 52-week high: $43.15 on Nov 12, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Viking Therapeutics report earnings?
The next quarterly report is on Feb 10, 2027. Last quarter, earnings per share changed −91% year over year, revenue 0%.
Does Viking Therapeutics pay dividends?
No, Viking Therapeutics does not pay dividends.
Where does Viking Therapeutics trade and how to buy it?
Ticker VKTX, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy Viking Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for VKTX are in the terminal after you log in.